Question 4

Only the pre-certification provision occurs before the treatment is provided.

Pre-certification provision is specifically focused on obtaining authorization prior to the start of treatment, which distinguishes it from concurrent review that takes place during the course of treatment.

A) is designed to be a cost containment measure.

While pre-certification can serve as a cost containment measure, this characteristic is not exclusive to it. Concurrent review also aims to manage costs by evaluating ongoing treatment, thus this option does not accurately address the primary difference.

B) involves a review by the physician.

Both pre-certification and concurrent review involve a review process that may include a physician's evaluation. Hence, this statement does not highlight a unique aspect of pre-certification and can lead to confusion regarding the distinguishing factors.

C) requires the consent of the patient.

Patient consent is generally a standard practice in both pre-certification and concurrent review processes. Therefore, this option does not illustrate a clear distinction exclusive to pre-certification.

D) occurs before the treatment is provided.

This statement accurately captures a key difference, as pre-certification is specifically conducted prior to the initiation of treatment, ensuring that the proposed services are deemed necessary and appropriate before they are delivered.

Conclusion

The correct answer emphasizes that pre-certification occurs before treatment, which is a fundamental aspect that sets it apart from concurrent review. All other options fail to highlight a unique characteristic of pre-certification, as they either apply to both processes or do not accurately reflect the core distinction.